Home / KEEP BUT DO NOT DISPLAY (page 11)

KEEP BUT DO NOT DISPLAY

MRI Technique Can Help Detect Pancreatic Inflammation

Ferumoxytol-MRI provided clear images of ongoing pancreatic inflammation in patients with new-onset type 1 diabetes. Using the technique may help identify patients showing diabetes progression and stratify subgroups that may respond to various treatments. The researchers investigated the possibility of using MRI and ferumoxytol, a coated iron nanoparticle used as …

Read More »

Smartphones Effective in Measuring Physical Activity

Researchers found smartphones were as effective as pedometers and accelerometers in monitoring number of steps. Study subjects walked on a treadmill wearing a pedometer, accelerometer and smartphone. The study patients wore all of the devices at the same time. The patients performed four walks with the treadmill set at 3 …

Read More »

Probiotics May Help Prevent Diabetes

Seventeen healthy individuals were split into two groups both maintaining their habitual food intake for the first three weeks of the study. One of the groups also consumed two bottles of a probiotic fermented milk drink every day. During the fourth week, both groups were given a high-fat and high-energy …

Read More »

Chemical in Red Wine Helps to Burn Fat

According to a new study, ellagic acid retards the growth of fat cells, and slows down the formation of new ones. It also boosts the metabolism of fatty acids in the liver. In a 10-week trial, scientists fed high-fat “mouse chow” to mice. Half were also given extracts from Pinot …

Read More »

Effect of Lifestyle Intervention in Type 2s

A meta-analysis of 16 studies found that lifestyle intervention in patients with type 2 diabetes significantly improved BMI, HbA1c, systolic blood pressure, and diastolic blood pressure compared with standard care. The authors reviewed evidence that lifestyle interventions (nutrition therapy, physical activity, and education) compared with usual care/control groups improve risk …

Read More »

Afrezza Now Available in U.S.

Sanofi and MannKind have announced that their inhaled insulin powder, Afrezza, is now available in the U.S. The product is administered via a small, portable inhaler to help boost glucose control in diabetes patients.

Read More »

Preventing Duplicate Test Orders Reduces Costs

Unnecessary laboratory tests can be reduced by blocking physicians from ordering the same test for hospitalized patients more than once a day. A new program at Cleveland Clinic employed a clinical decision support tool to block duplicate test orders during the computerized physician order entry process each day and to …

Read More »

Reducing Fructose Intake Could Reduce Diabetes-related Morbidity

James J. DiNicolantonio, PharmD, of Saint Luke’s Mid America Heart Institute in Kansas City, Mo stated that reducing intake of added fructose and other added sugars could reduce diabetes-related morbidity. He added that added fructose increases risk of diabetes, diabetes-related metabolic abnormalities, and cardiovascular issues. In contrast, whole foods containing …

Read More »